Articles with "argatroban" as a keyword



Photo from wikipedia

Thrombin inhibitor argatroban modulates bone marrow stromal cells behaviors and promotes osteogenesis through canonical Wnt signaling.

Sign Up to like & get
recommendations!
Published in 2021 at "Life sciences"

DOI: 10.1016/j.lfs.2021.119073

Abstract: AIMS Coagulation is a common event that play a double-edged role in physiological and pathological process. Anti-coagulation methods were applied in joint surgery or scaffolds implantation to encourage new vascular formation and avoid coagulation block.… read more here.

Keywords: argatroban; coagulation; inhibitor argatroban; marrow stromal ... See more keywords
Photo by winstontjia from unsplash

Argatroban et thrombopénie induite par l’héparine : observatoire des modalités de prescription et d’utilisation en France

Sign Up to like & get
recommendations!
Published in 2020 at "Therapie"

DOI: 10.1016/j.therap.2019.12.008

Abstract: Resume Objectif Un observatoire de prescription a ete mis en place en France afin de s’assurer du bon usage de l’argatroban pendant les 18 premiers mois de sa commercialisation, pour l’anticoagulation de l’adulte ayant une thrombopenie… read more here.

Keywords: prescription; argatroban; par; induite par ... See more keywords
Photo by jontyson from unsplash

528: COMPARING ARGATROBAN AND UNFRACTIONATED HEPARIN FOR PEDIATRIC VTE A SINGLE-CENTER STUDY

Sign Up to like & get
recommendations!
Published in 2019 at "Critical Care Medicine"

DOI: 10.1097/01.ccm.0000551280.71714.4a

Abstract: Learning Objectives: The current standard of care for parenteral treatment of venous thromboembolism (VTE) in the acute setting is anticoagulation with unfractionated heparin. This treatment has known limitations. Direct thrombin inhibitors, such as argatroban, have… read more here.

Keywords: goal; heparin; argatroban; time ... See more keywords
Photo from wikipedia

643: NOVEL MONITORING AND DOSE ADJUSTMENT OF ARGATROBAN TO MAINTAIN THERAPEUTIC ANTICOAGULATION

Sign Up to like & get
recommendations!
Published in 2021 at "Critical Care Medicine"

DOI: 10.1097/01.ccm.0000808896.58206.d1

Abstract: INTRODUCTION: In patients with unreliable activated partial thromboplastin time (aPTT) measurements who require anticoagulation with a direct thrombin inhibitor (DTI), the only reliable alternative measurement at present is a dilute thrombin time (dTT). However, this… read more here.

Keywords: time; argatroban; maintain therapeutic; anticoagulation ... See more keywords
Photo from wikipedia

Membrane oxygenator longevity was higher in argatroban‐treated patients undergoing vvECMO

Sign Up to like & get
recommendations!
Published in 2023 at "European Journal of Clinical Investigation"

DOI: 10.1111/eci.13963

Abstract: In severe acute respiratory distress syndrome (ARDS), venovenous extracorporeal membrane oxygenation (vvECMO) can be a lifesaver. However, anticoagulation therapy is mandatory because the nonendothelial extracorporeal surface increases the risk of thromboembolic problems. Heparin is still… read more here.

Keywords: higher argatroban; membrane oxygenator; longevity higher; oxygenator longevity ... See more keywords
Photo from wikipedia

Efficacy and safety of argatroban in treatment of acute ischemic stroke: A meta-analysis

Sign Up to like & get
recommendations!
Published in 2022 at "World Journal of Clinical Cases"

DOI: 10.12998/wjcc.v10.i2.585

Abstract: BACKGROUND Argatroban is a novel direct thrombin inhibitor that has been used for treatment of acute ischemic stroke (AIS). To our knowledge, no systematic analysis has assessed the efficacy and safety of argatroban for treatment… read more here.

Keywords: safety argatroban; argatroban; analysis; efficacy safety ... See more keywords